Article Information
History
- October 23, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Xue Li1,2,3,#,
- Le Gao2,#,
- Xinning Tong1,
- Vivien K.Y. Chan2,
- Celine S.L. Chui3,4,5,
- Francisco T.T. Lai2,3,
- Carlos K.H. Wong2,6,
- Eric Y.F. Wan2,3,6,
- Esther W.Y. Chan2,3,
- Kui Kai Lau1,8,
- Chak Sing Lau1 and
- Ian C.K. Wong2,3,7,9,*
- 1Department of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
- 2Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
- 3Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Sha Tin, Hong Kong SAR, China
- 4School of Nursing, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
- 5School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
- 6Department of Family Medicine and Primary Care, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China
- 7Research Department of Practice and Policy, School of Pharmacy, University College London, United Kingdom
- 8The State Key Laboratory of Brain and Cognitive Sciences, The University of Hong Kong, Hong Kong SAR, China
- 9Expert Committee on Clinical Events Assessment Following COVID-19 Immunization, Department of Health, The Government of the Hong Kong Special Administrative Region, Hong Kong SAR, China
- ↵*Corresponding author wongick{at}hku.hk
↵# Co-first author. XL and LG contributed equally to this article.
Posted October 23, 2021.
Autoimmune conditions following mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccination: a descriptive cohort study among 1.1 million vaccinated people in Hong Kong
